Steven B Ratoff Eagle Pharmaceuticals, Inc. (EGRX) insider trading activity

EGRX Quotes by TradingView

Steven B Ratoff is Director of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 27,364 shares of EGRX, which is worth approximately $14,229. The most recent transaction as insider was on Apr 08, 2021, when has been sold 7,020 shares (Common Stock) at a price of $7.33 per share, resulting in proceeds of $51,457. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.4K
0% 3M change
0% 12M change
Total Value Held $14,229

STEVEN B RATOFF Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 08 2021
BUY
Exercise of conversion of derivative security
$51,457 $7.33 p/Share
7,020 Added 20.42%
27,364 Common Stock
Feb 28 2020
BUY
Exercise of conversion of derivative security
$20,545 $8.78 p/Share
2,340 Added 10.32%
20,344 Common Stock
SBR

Steven B Ratoff

Director
Woodcliff Lake, NJ

Track Institutional and Insider Activities on EGRX

Follow EAGLE PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EGRX shares.

Notify only if

Insider Trading

Get notified when an Eagle Pharmaceuticals, Inc. insider buys or sells EGRX shares.

Notify only if

News

Receive news related to EAGLE PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EGRX